FX006 32 mg
FX006-2015-009
Phase 3 small_molecule completed
Quick answer
FX006 32 mg for Osteoarthritis of the Knee is a Phase 3 program (small_molecule) at Pacira BioSciences with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Pacira BioSciences
- Indication
- Osteoarthritis of the Knee
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed